Potential health concerns of dietary phosphorus: Cancer, obesity, and hypertension

Annals of the New York Academy of Sciences

Volumn 1301, Issue 1, 2013, Pages 1-8

  Anderson, John J B ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Chronic diseases; High P diets; Hormones; Metabolic abnormalities

Indexed keywords

PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ARTICLE; BLOOD VESSEL CALCIFICATION; BREAST CANCER; CHRONIC DISEASE; COLON CANCER; DEATH; DISEASE COURSE; ENDOMETRIUM CANCER; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OBESITY; OVARY CANCER; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE INTAKE; RISK FACTOR; VASCULAR SMOOTH MUSCLE;

CHRONIC DISEASES; HIGH-P DIETS; HORMONES; METABOLIC ABNORMALITIES;

FIBROBLAST GROWTH FACTORS; FOOD; HUMANS; HYPERTENSION; NEOPLASMS; NUTRITION POLICY; OBESITY; PARATHYROID HORMONE; PHOSPHATES; PHOSPHORUS, DIETARY; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION;

EID: 84885484019     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12208     Document Type: Article

References (46)

1. Calvo, M.S. & Y.K. Park 1996. Changing phosphorus content of the US diet: potential for adverse effects on bone. J. Nutr. 126: 1168S-1180S.
2. Institute of Medicine. 2011. Dietary Reference Intakes: Calcium and Vitamin D. IOM, National Academies. Washington, DC. (See p 1109 for Phosphorus Recommended Dietary Allowances.)
3. Breslau, N.A. 1996. "Magnesium and phosphorus: intestinal absorption" [Chapter 7]. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd ed. M.J. Favus, Ed.: 41-49. Lippincott-Raven. Philadelphia.
4. Anderson, J.J.B. & R.V. Talmage 1973. The effect of calcium infusion and calcitonin on plasma phosphate in sham-operated and thyroparathyroidectomized dogs. Endocrinology 93: 1222-1226.
5. deBoer, I.H., T.C. Rue & B. Kestenbaum 2009. Serum phosphorus concentrations in the Third National Health and Examination Survey (NHANES III). Am. J. Kidney Dis. 53: 399-407.
6. Berndt, T. & R. Kumar 2009. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda, MD) 24: 17-25.
7. Juppner, H., W. Wolf & I.B. Salusky 2010. FGF-23: more than a regulator of renal phosphate handling? J. Bone Miner. Res. 25: 2091-2097.
8. Quarles, L.D. 2012. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat. Rev. Endocrinol. 8: 276-286.
9. Zhang, R, Y. Lu, L. Ye, et al. 2011. Unique roles of phosphorus in endochondral bone formation and osteocyte maturation. J. Bone Miner. Res. 26: 1047-1056.
10. Ben-Dov, I.Z., H. Galitzer, V. Lavi-Moshayoff, et al. 2007. The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117: 4003-4008.
11. Peterlik, M. & R.H. Wasserman 1980. Regulation by vitamin D of intestinal phosphate absorption. Horm. Metab. Res. 12: 216-219.
12. Pitroda, A.P., S.S. Harris & B. Dawson-Hughes 2009. The association of obesity with parathyroid hormone in healthy older adults. Endocrine 36: 218-223.
13. Palmer, S.C., A. Hayen, P. Macaskill, et al. 2011. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305: 1119-1127.
14. Bates, C.J., M. Hamer & G.D. Mishra 2012. A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: the National Diet and Nutrition Survey of people aged 65 years and older. Osteoporos. Int. 23: 457-466.
15. Ix, J.H., R. Katz, B.R. Kestenbaum, et al. 2012. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals. J. Am. Coll. Cardiol. 60: 200-207.
16. Dominquez, J.R., B. Kestenbaum, M. Chonchoi, et al. 2013. Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: the Osteoporotic Fractures in Men (MrOS) Study. Am. J. Kidney Dis. 61: 555-563. DOI: 10.1053/j.ajkd.2012.11.033.
17. Hers, I., E.E. Vincent & J.M. Tavare 2011. Akt signaling in health and disease. Cell Signal 23: 1515-1527.
18. Tenenhouse, H.S. 2007. Phosphate transport: molecular basis, regulation and pathophysiology. J. Steroid Biochem. Mol. Biol. 103: 572-577.
19. Ellam, T.J. & T.J.A. Chico 2012. Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 22: 310-318.
20. Chang, S.H., K.N. Yu, Y.-S. Lee, et al. 2006. Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells. Am. J. Respir. Cell Mol. Biol. 35: 528-539.
21. Jin, H., C.-X. Xu, H.-T. Lim, et al. 2009. High dietary phosphate increases lung tumorigenesis and alters Akt signaling. Am. J. Respir. Crit. Care Med. 179: 59-68.
22. Xu, C.-X., H. Jin, H.-T. Lim, et al. 2008. High dietary inorganic phosphate enhances cap-dependent protein translation, cell-cycle progression, and angiogenesis in the livers of young mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G654-G663.
23. Spina, A., L. Sapi, S. Esposito, et al. 2013. Inorganic phosphate as a novel signaling molecule with antiproliferative action in MDA-MB-231 breast cancer cells. BioRes. Open Access 1: 47-54.
24. Spina, A., L. Sorvillo, F. Di Maiolo, et al. 2013. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. J. Cell Physiol. 228: 198-206.
25. Takata, Y., X.-O. Shu, G. Yang, et al. 2012. Calcium intake and lung cancer risk among female nonsmokers: a report from the Shanghai Women's Health Study. Cancer Epidemiol. Biomarkers Prev. 22: 50-57.
26. Bernstein, A.M., L. de Koning, A.J. Flint, et al. 2012. Soda consumption and the risk of stroke in men and women. Am. J. Clin. Nutr. 95: 1190-1199.
27. Malik, V.S., B.M. Popkin, G.A. Bray, et al. 2012. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes. Diabetes Care 33: 2477-2483.
28. Gilardini, L., L. Pasqualinotto, S. Di Matteo, et al. 2011. Factors associated with early atherosclerosis and arterial calcifications in young subjects with a benign phenotype of obesity. Obesity 19: 1684-1689.
29. Saab, G., A. Whaley-Connell, S.I. McFarlaine, et al. 2010. Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease. Metabolism 59: 385-389.
30. Grethen, E., K.M. Hill, R.M. Jones, et al. 2012. Serum leptin, parathyroid hormone, 1, 25-dihydroxyviatmin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J. Clin. Endocrinol. Metab. 97: 1655-1662.
31. Grethen, E., R. McClintock, C.E. Gupta, et al. 2011. Vitamin D and hyperparathyroidism in obesity. J. Clin. Endocrinol. Metab. 96: 1320-1326.
32. Sitara, D., S. Kim, M.S. Razzaque, et al. 2008. Genetic evidence of serum-phosphate independent functions of FGF-23 on bone. PLOS Genet 4: e100154.
33. Alonso, A.A., J.J. Beunza, M. Delgado-Rodriquez, et al. 2005. Low-fat dairy consumption and reduced risk of hypertension: the Seguiemiento Universidad de Navarra (SUN) cohort. Am. J. Clin. Nutr. 82: 972-979.
34. Engberink, M.F., M.H. Hendriksen, E.G. Schouten, et al. 2009. Inverse association between dairy intake and hypertension: the Rotterdam Study. Am. J. Clin. Nutr. 89: 1877-1883.
35. Alonso, A., J.A. Nettleton, J.H. Ix, et al. 2010. Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis. Hypertension 55: 776-784.
36. Appel, L.J., T.J. Moore, E. Obarzanek, et al. 1997. A clinical trial of the effects of dietary patterns on blood pressure. N. Engl. J. Med. 336: 1117-1124.
37. Appel, L.J., M.W. Brands, S.R. Daniels, et al. 2006. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47: 296-308.
38. Ralston, R.A., J.H. Lee, H. Truby, et al. 2012. A systemic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J. Hum. Hypertens. 26: 3-13.
39. Tonelli, M., F. Sacks, M. Pfeiffer, et al. 2005. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633.
40. Snijder, M.B., P. Lips, J.C. Sidell, et al. 2007. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J. Intern. Med. 261: 588-565.
41. Bolland, M.J., P.A. Barber, R.M. Doughty, et al. 2008. Vascular vents in healthy older women receiving calcium supplementation: randomized controlled trial. BMJ 336: 262-266.
42. Xiao, Q., R.A. Murphy, D.K. Houston, et al. 2013. Dietary and supplemental calcium intake and cardiovascular disease mortality. JAMA Intern. Med. 173: 639-646. doi: 10.1001/jamainternmed.2013.3283.
43. Jono, S., M.D. McKee, C.E. Murry, et al. 2000. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 87: e10-e17.
44. Lau, W.L., A. Pai, S.M. Moe & C.M. Giachelli 2011. Direct effects of phosphate on vascular cell function. Adv. Chronic Kidney Dis. 18: 105-112.
45. Kemi, V.E., M.U.M. Karkkainen, H.J. Rita, et al. 2010. Low calcium-to-phosphorus ratio in habitual diets affects serum parathyroid hormone concentration and calcium metabolism in healthy women with adequate calcium intake. Br. J. Nutr. 103: 561-568.
46. Camalier, C.E., M. Yi, L.-R. Yu, et al. 2012. An integrated understanding of the physiological response to elevated extracellular phosphate. J. Cell Physiol. doi: 10.1002/jcp.24312.